Hester Biosciences Limited (BOM:524669)

Hester Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	19,711	10,741	10,667	11,818	12,934	23,099
Market Cap Growth	8.59%	0.70%	-9.74%	-8.63%	-44.00%	41.66%
Enterprise Value	21,669	12,929	13,063	14,503	15,490	24,167
Last Close Price	2317.10	1257.16	1244.14	1375.11	1498.02	2663.40

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	14.66	19.31	38.81	62.57	48.58	58.75
Forward PE	-	39.50	39.50	39.50	32.93	53.45
PS Ratio	6.02	3.22	3.41	3.80	4.65	9.37
PB Ratio	5.36	2.92	3.27	3.90	4.48	8.64
P/TBV Ratio	5.62	3.06	3.47	4.11	4.67	8.96
P/FCF Ratio	42.56	23.19	24.29	49.69	-	-
P/OCF Ratio	30.73	16.75	16.54	24.53	54.82	265.14
PEG Ratio	-	3.05	3.05	3.05	3.05	3.11

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	6.62	3.87	4.18	4.66	5.57	9.80
EV/EBITDA Ratio	23.33	15.83	23.22	24.17	24.81	33.90
EV/EBIT Ratio	29.38	18.66	28.63	33.63	36.86	43.91
EV/FCF Ratio	46.79	27.92	29.74	60.97	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.53	0.53	0.65	0.85	0.95	0.85
Debt / EBITDA Ratio	2.28	2.21	3.43	4.28	4.38	3.19
Debt / FCF Ratio	-	4.21	4.86	10.84	-	-
Net Debt / Equity Ratio	0.51	0.51	0.63	0.80	0.90	0.76
Net Debt / EBITDA Ratio	2.38	2.31	3.66	4.04	4.16	2.85
Net Debt / FCF Ratio	-	4.07	4.69	10.19	-4.79	-2.33
Asset Turnover	-	0.50	0.48	0.47	0.45	0.51
Inventory Turnover	-	1.23	1.27	1.24	1.03	0.99
Quick Ratio	-	0.72	0.70	0.95	0.68	0.85
Current Ratio	-	1.37	1.56	2.04	1.53	2.01
Return on Equity (ROE)	-	16.55%	9.16%	7.16%	10.09%	15.69%
Return on Assets (ROA)	-	6.51%	4.33%	4.05%	4.26%	7.07%
Return on Invested Capital (ROIC)	10.39%	9.65%	6.17%	5.23%	5.76%	10.22%
Return on Capital Employed (ROCE)	-	13.20%	8.60%	7.70%	8.10%	11.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	6.91%	5.18%	2.58%	1.60%	2.06%	1.70%
FCF Yield	2.35%	4.31%	4.12%	2.01%	-4.19%	-3.77%
Dividend Yield	0.50%	0.88%	0.56%	0.44%	0.53%	0.38%
Payout Ratio	-	10.83%	18.80%	36.28%	31.95%	21.63%
Total Shareholder Return	1.78%	0.88%	0.56%	0.44%	0.53%	0.38%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error